Li Yangyang, Yang Gengqiang, Li Qiyang, Zhang Yiming, Zhang Shangzu, Zhou Ting, Wang Xin, Liu Fuxian, Miao Zhiming, Qi Yafeng, Zhang Liying, Liu Yongqi, Su Haixiang
Gansu University of Chinese Medicine, Provincial Key Laboratory of Molecular Medicine and Prevention Research of Major Diseases, Lanzhou 730000, PR China.
Department of Genetics and Cell Biology, School of Basic Medicine, Qingdao University, Qingdao 266071, PR China.
Phytomedicine. 2025 May;140:156591. doi: 10.1016/j.phymed.2025.156591. Epub 2025 Mar 6.
Radiotherapy is one of the main treatments for non-small cell lung cancer (NSCLC), and radiosensitivity is a determinant of its efficacy. Therefore, enhancing the radiosensitivity is of great significance to improve the clinical efficacy of non-small cell lung cancer (NSCLC).
This study intended to investigate the radiosensitisation effect and mechanism of Guiqi Baizhu decoction (GQBZD) on non-small cell lung cancer (NSCLC) and the role of hypoxia-inducible factor-1 alpha (HIF-1α)/DNA-dependent protein kinase catalytic subunit (DNA-PKcs) axis-mediated DNA non-homologous end joining (NHEJ) repair in NSCLC radiotherapy.
In vivo experimental model was Lewis subcutaneous transplantation tumor model of in C57 black 6 (C57BL/6) mice, and in vitro experimental models were A549, H1299 and H460 cells.
In vivo experimental model was Lewis subcutaneous transplantation tumor model of in C57 black 6 (C57BL/6) mice. After the model was successfully established, the tumor was irradiated locally with 4 Gy X-ray, and 10.465 g/kg Guiqi Baizhu Decoction (GQBZD) was administered by gavage on the second day after irradiation for a total of 10 days. The morphological changes in tumour tissues were observed by HE staining, Ki67 levels in tumour tissues were detected by immunohistochemistry, the apoptosis in tumour cells were detected by Tunel staining. In vitro experimental models were different NSCLC cells (A549, H1299 and H460), irradiated by 2 Gy X-rays and then intervened with 5%, 10% and 20% Guiqi Baizhu Decoction (GQBZD)-containing serum for 24 h. A549 stably-transformed cell lines knocking down and overexpressing HIF-1α were also constructed by lentiviral transfection. The cell proliferation was detected by CCK-8 and clone formation, the apoptosis and cell cycle was detected by flow cytometry. Network pharmacology and transcriptomics to investigate key targets and pathways of GQBZD effects on NSCLC irradiation, further validated by immunofluorescence and Western blot.
In vivo experiments confirmed that GQBZD combined with irradiation could inhibit the growth of Lewis subcutaneous transplantation tumor, reduce the expression of Ki67 and promote the apoptosis of tumour cells. In vitro experiments confirmed that GQBZD combined with irradiation inhibited the proliferation of different NSCLC cells, promoted NSCLC cell apoptosis and G2/M-phase arrest, and induced the expression of phosphorylated histone H2AX (γ-H2AX) in NSCLC cells, which showed a good radiosensitisation effect. Mechanistically, GQBZD exerts its radiosensitisation effect on NSCLC mainly through the HIF-1α signalling pathway. Meanwhile, under irradiation conditions, the expression of HIF-1α and DNA-PKcs were positively correlated, and HIF-1α had a regulatory effect on DNA-PKcs, promoting DNA-PKcs-dependent non-homologous end joining (NHEJ) repair. In addition, GQBZD combined irradiation down-regulated the expression of HIF-1α, DNA-PKcs, and NHEJ repair-related proteins in NSCLC cells, while reversing the expression of HIF-1α, DNA-PKcs, and NHEJ repair-related proteins in overexpressing HIF-1α A549 cell, thereby enhancing radiosensitivity in NSCLC.
This study provides an in-depth exploration of the radiosensitisation effect of GQBZD and provides an important experimental basis for the study of Chinese medicine in the field of cancer radiosensitisation, and further extends the extensibility of GQBZD on the basis of the previous study.
放射治疗是非小细胞肺癌(NSCLC)的主要治疗方法之一,放射敏感性是其疗效的决定因素。因此,提高放射敏感性对提高非小细胞肺癌(NSCLC)的临床疗效具有重要意义。
本研究旨在探讨归芪白术汤(GQBZD)对非小细胞肺癌(NSCLC)的放射增敏作用及机制,以及缺氧诱导因子-1α(HIF-1α)/DNA依赖性蛋白激酶催化亚基(DNA-PKcs)轴介导的DNA非同源末端连接(NHEJ)修复在NSCLC放疗中的作用。
体内实验模型为C57黑6(C57BL/6)小鼠的Lewis皮下移植瘤模型,体外实验模型为A549、H1299和H460细胞。
体内实验模型为C57黑6(C57BL/6)小鼠的Lewis皮下移植瘤模型。模型成功建立后,用4 Gy X射线对肿瘤进行局部照射,照射后第二天开始灌胃给予10.465 g/kg归芪白术汤(GQBZD),共10天。通过HE染色观察肿瘤组织的形态变化,免疫组化检测肿瘤组织中Ki67水平,Tunel染色检测肿瘤细胞凋亡。体外实验模型为不同的NSCLC细胞(A549、H1299和H460),用2 Gy X射线照射后,分别用含5%、10%和20%归芪白术汤(GQBZD)的血清干预24 h。还通过慢病毒转染构建了敲低和过表达HIF-1α的A549稳定转化细胞系。采用CCK-8和克隆形成检测细胞增殖,流式细胞术检测细胞凋亡和细胞周期。通过网络药理学和转录组学研究GQBZD对NSCLC放疗作用的关键靶点和途径,并通过免疫荧光和Western blot进一步验证。
体内实验证实,GQBZD联合照射可抑制Lewis皮下移植瘤的生长,降低Ki67表达,促进肿瘤细胞凋亡。体外实验证实,GQBZD联合照射可抑制不同NSCLC细胞的增殖,促进NSCLC细胞凋亡和G2/M期阻滞,并诱导NSCLC细胞中磷酸化组蛋白H2AX(γ-H2AX)的表达,显示出良好的放射增敏作用。机制上,GQBZD主要通过HIF-1α信号通路对NSCLC发挥放射增敏作用。同时,在照射条件下,HIF-1α与DNA-PKcs的表达呈正相关,HIF-1α对DNA-PKcs具有调节作用,促进DNA-PKcs依赖性非同源末端连接(NHEJ)修复。此外,GQBZD联合照射可下调NSCLC细胞中HIF-1α、DNA-PKcs和NHEJ修复相关蛋白的表达,同时逆转过表达HIF-1α的A549细胞中HIF-1α、DNA-PKcs和NHEJ修复相关蛋白的表达,从而增强NSCLC的放射敏感性。
本研究对GQBZD的放射增敏作用进行了深入探讨,为中医药在癌症放射增敏领域的研究提供了重要的实验依据,并在前人研究的基础上进一步拓展了GQBZD的应用范围。